Ngow, H. A., Teh , L. K., Langmia, I. M., Lew, W. L., Harun, R., Ismail, R., & Salleh, M. Z. (2008). Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: A 6-month follow-up study. Informa Plc.
Chicago Style (17th ed.) CitationNgow, Harris Abdullah, Lay Kek Teh , I. M. Langmia, W. L. Lew, R. Harun, R. Ismail, and Mohd Zaki Salleh. Role of Pharmacodiagnostic of CYP2C9 Variants in the Optimization of Warfarin Therapy in Malaysia: A 6-month Follow-up Study. Informa Plc, 2008.
MLA (8th ed.) CitationNgow, Harris Abdullah, et al. Role of Pharmacodiagnostic of CYP2C9 Variants in the Optimization of Warfarin Therapy in Malaysia: A 6-month Follow-up Study. Informa Plc, 2008.
Warning: These citations may not always be 100% accurate.